These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28394260)

  • 1. Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription.
    Patitucci C; Couchy G; Bagattin A; Cañeque T; de Reyniès A; Scoazec JY; Rodriguez R; Pontoglio M; Zucman-Rossi J; Pende M; Panasyuk G
    J Clin Invest; 2017 May; 127(5):1873-1888. PubMed ID: 28394260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation.
    Rebouissou S; Imbeaud S; Balabaud C; Boulanger V; Bertrand-Michel J; Tercé F; Auffray C; Bioulac-Sage P; Zucman-Rossi J
    J Biol Chem; 2007 May; 282(19):14437-46. PubMed ID: 17379603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ.
    Chen J; Wang W; Qi Y; Kaczorowski D; McCaughan GW; Gamble JR; Don AS; Gao X; Vadas MA; Xia P
    Biochim Biophys Acta; 2016 Feb; 1861(2):138-147. PubMed ID: 26615875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice.
    Kineman RD; Majumdar N; Subbaiah PV; Cordoba-Chacon J
    Endocrinology; 2016 May; 157(5):1728-35. PubMed ID: 26950202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1α) in adult liver and controls expression of frizzled-6.
    Krützfeldt J; Rösch N; Hausser J; Manoharan M; Zavolan M; Stoffel M
    Hepatology; 2012 Jan; 55(1):98-107. PubMed ID: 21887698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake.
    Labrie M; Lalonde S; Najyb O; Thiery M; Daneault C; Des Rosiers C; Rassart E; Mounier C
    PLoS One; 2015; 10(6):e0130230. PubMed ID: 26083030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
    Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
    Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
    Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
    Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ contributes to PKM2 and HK2 expression in fatty liver.
    Panasyuk G; Espeillac C; Chauvin C; Pradelli LA; Horie Y; Suzuki A; Annicotte JS; Fajas L; Foretz M; Verdeguer F; Pontoglio M; Ferré P; Scoazec JY; Birnbaum MJ; Ricci JE; Pende M
    Nat Commun; 2012 Feb; 3():672. PubMed ID: 22334075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered composition of fatty acids exacerbates hepatotumorigenesis during activation of the phosphatidylinositol 3-kinase pathway.
    Kudo Y; Tanaka Y; Tateishi K; Yamamoto K; Yamamoto S; Mohri D; Isomura Y; Seto M; Nakagawa H; Asaoka Y; Tada M; Ohta M; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Maeda S; Shiina S; Yoshida H; Nakajima O; Kanai F; Omata M; Koike K
    J Hepatol; 2011 Dec; 55(6):1400-8. PubMed ID: 21703185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
    Yu S; Viswakarma N; Batra SK; Sambasiva Rao M; Reddy JK
    Biochimie; 2004 Nov; 86(11):743-61. PubMed ID: 15589683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis.
    Pelletier L; Rebouissou S; Paris A; Rathahao-Paris E; Perdu E; Bioulac-Sage P; Imbeaud S; Zucman-Rossi J
    Hepatology; 2010 Feb; 51(2):557-66. PubMed ID: 20041408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
    Nan YM; Han F; Kong LB; Zhao SX; Wang RQ; Wu WJ; Yu J
    Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct pathways of genomic progression to benign and malignant tumors of the liver.
    Tward AD; Jones KD; Yant S; Cheung ST; Fan ST; Chen X; Kay MA; Wang R; Bishop JM
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14771-6. PubMed ID: 17785413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
    Geng T; Xia L; Russo S; Kamara D; Cowart LA
    Nutr Res; 2015 Sep; 35(9):812-22. PubMed ID: 26277244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice.
    Zeng X; Lin Y; Yin C; Zhang X; Ning BF; Zhang Q; Zhang JP; Qiu L; Qin XR; Chen YX; Xie WF
    Hepatology; 2011 Dec; 54(6):2036-47. PubMed ID: 21898499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts.
    Morán-Salvador E; López-Parra M; García-Alonso V; Titos E; Martínez-Clemente M; González-Périz A; López-Vicario C; Barak Y; Arroyo V; Clària J
    FASEB J; 2011 Aug; 25(8):2538-50. PubMed ID: 21507897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression.
    Mwangi SM; Peng S; Nezami BG; Thorn N; Farris AB; Jain S; Laroui H; Merlin D; Anania F; Srinivasan S
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G103-16. PubMed ID: 26564715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNF1
    Tan J; Xu J; Wei G; Zhang L; Sun L; Wang G; Li F; Jiang F
    J Diabetes Res; 2019; 2019():5483946. PubMed ID: 31223625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.